Wentworth Kory James

Chief Financial Officer

1 company

Good

Trades Analyzed

12M Win Rate

48.1%

Avg 3M Return

+4.3%

Avg 12M Return

+6.4%

Wentworth Kory James is a Chief Financial Officer at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.

Estimated insider holdings value: $862K based on current market prices.

Holdings by Company

TRDAMar 10, 2026

Current Shares121.5K

Value$861.5K

Net Activity-118,328

Bought: 0Sold: 118.3K

Showing 9 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 11, 2023	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	10,000	$17.99	$179,862.18	-12.0%	-20.9%	-12.6%
Jun 21, 2023	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	17,500	$15.01	$262,648.25	-21.3%	-5.1%	-4.7%
Mar 2, 2023	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	1,747	$10.53	$18,389.01	-2.0%	+12.9%	+35.3%
Dec 8, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	4,550	$18.95	$86,237.97	-21.6%	-45.6%	-32.2%
Dec 5, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	3,110	$18.19	$56,559.49	-8.6%	-41.6%	-21.8%
Nov 16, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	200	$18.10	$3,620.00	-1.2%	-25.3%	-11.9%
Aug 25, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	4,669	$13.78	$64,361.54	-11.4%	-2.0%	+7.7%
Aug 23, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	11,655	$13.08	$152,432.02	-20.0%	+9.8%	+25.3%
Aug 18, 2022	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	600	$13.02	$7,814.00	-1.0%	+35.2%	+22.1%